Small cell carcinoma of the stomach: A clinicopathologic study of 17 cases
K Matsui M Kitagawa A Miwa Y Kuroda M Tsuji 1991 Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases Am J Gastroenterol 86 1167 75
Clinicopathologic features of neuroendocrine carcinoma of the stomach. Appraisal of small cell and large cell variants
K Matsuki XM Jin M Kitagawa A Miwa 1998 Clinicopathologic features of neuroendocrine carcinoma of the stomach. Appraisal of small cell and large cell variants Arch Pathol Lab Med 122 1010 7
Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinoma
A Van Der Gaast J Verwey E Prins TA Splinter 1990 Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinoma Cancer 65 422 4
Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxity of 5-fluorouracil by two biochemical modulators
T Shirasaka Y Shimamoto H Ohshimo M Yamaguchi T Kato K Yonekura 1996 Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548 57
An early phase II study of oral TS-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers
K Sugimachi Y Maehara N Horikoshi Y Shimada Y Sakata Y Miyachi 1999 An early phase II study of oral TS-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers Oncology 57 202 10
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
W Koizumi S Tanabe K Saigenji A Ohtsu N Boku F Nagashima 2003 Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207 12
Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer
Y Sakaguchi A Kabashima K Okita Y Ojima S Yamamura T Nishizaki 2005 Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer Gastric Cancer 8 111 6
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
K Noda Y Nishiwaki M Kawahara S Negoro T Sugiura A Yokoyama 2002 Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer N Engl J Med 346 85 91
Small cell carcinoma of the esophagus with reference to alternating multiagent chemotherapy: Report of two cases
N Koide M Hiraguri K Kishimoto T Nakamura W Adachi H Miyabayashi 2003 Small cell carcinoma of the esophagus with reference to alternating multiagent chemotherapy: report of two cases Surg Today 33 294 8
The effectiveness of chemotherapy with cisplatin and 5-fluorouracil for recurrent small cell neuroendocrine carcinoma of the rectum: Report of a case
T Okuyama D Korenaga S Tamura T Yao S Maekawa A Watanabe 1999 The effectiveness of chemotherapy with cisplatin and 5-fluorouracil for recurrent small cell neuroendocrine carcinoma of the rectum: report of a case Surg Today 29 165 9
Advanced gastric endocrine cell carcinoma with distant lymph node metastasis: A case report and clinicopathological characteristics of the disease
N Chiba T Suwa M Hori M Sakuma M Kitajima 2004 Advanced gastric endocrine cell carcinoma with distant lymph node metastasis: a case report and clinicopathological characteristics of the disease Gastric Cancer 7 122 7